Fineotex Chemical Limited (FCL)
₹57.25 -1.12% last close, 16 Oct
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Fineotex Chemical's revenue was ₹377 Cr (+174.8% year on year, +20.0% on the previous quarter), and net profit ₹48.2 Cr (+92.6% year on year); the operating margin was 15.7%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹377 | +174.8% | +20.0% |
| Operating profit | ₹59.1 | +134.7% | +35.4% |
| Net profit | ₹48.2 | +92.6% | +10.1% |
| EPS (₹) | 0.41 | +88.1% | +7.9% |
| Operating margin | 15.7% | — | — |
EPS restated for the ₹2 to ₹1 split of Oct 2025 and the 4:1 bonus of Oct 2025: Q1 FY26 ₹2.18 to ₹0.22.
FCL delivery percentage and bulk deals
NSE end-of-day data for
On Fri, 16 Oct 2026, 34.34% of the FCL shares traded on NSE were taken to delivery, against the stock's own 20-session average of 29.58%. That is close to its usual level. It closed at a price band (circuit) on 1 session in about the last 20. 1 bulk or block deal was reported in FCL in the last 60 days: ₹38 Cr bought, none sold.
Delivery in the last 5 sessions: 31.9% · 24.8% · 35.1% · 34.1% · 34.3%
| Date | Side | Counterparty | Value | Price | Quantity | Type |
|---|---|---|---|---|---|---|
| 14 Oct | Buy | Mohamed Irfan Mohamed Latif Shaikh | ₹37.83 Cr | ₹60.04 | 6,300,000 | Bulk |
A description of what the exchange published, not a recommendation. Names such as "accumulation" or "long buildup" label a pattern in the numbers. How delivery is analysed
📢 Recent Corporate Announcements
Fineotex Chemical Limited has submitted its compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. The certificate was issued by its Registrar & Share Transfer Agent, Bigshare Services Private Limited, on October 10, 2026. Bigshare confirmed that all securities received for dematerialization were processed, mutilated, and cancelled within the prescribed 15-day period. This is a standard quarterly regulatory submission with no impact on business operations or financials.
- Compliance certificate submitted under Regulation 74(5) for the quarter ended September 30, 2026
- RTA Bigshare Services Private Limited issued the confirmation on October 10, 2026
- Security certificates received for demat were verified and cancelled within 15 days of receipt
Fineotex Chemical Limited (FCL) announced that its wholly owned subsidiary, Fineotex Biotex HealthGuard FZE, has incorporated a 100% step-down subsidiary in Delaware, USA, named Fineotex America Inc. The new entity currently has nil turnover and requires no cash acquisition consideration. It will focus on advanced water treatment chemicals and solutions for data centers and semiconductor manufacturing, diversifying FCL beyond textile chemicals into high-margin segments. This initiative aligns with FCL's strategy to expand non-textile offerings across international markets.
- Incorporated wholly owned step-down subsidiary Fineotex America Inc. in Delaware, USA
- Parent entity Fineotex Biotex HealthGuard FZE holds 100% share capital
- Turnover of the newly incorporated entity is NIL as of incorporation
- Targets high-growth niche of water treatment solutions for US data centers and semiconductor manufacturing
- Intimation received on September 24, 2026 (document references certificate date August 24, 2026)
Fineotex Chemical Limited has disclosed the voting results and scrutinizer's report for its 23rd AGM held on September 11, 2026. All six resolutions were approved, including financial statement adoption, dividend confirmation, and director re-appointment. Notably, an enabling special resolution for raising funds passed with 98.58% overall votes, despite 60.90% of public institutional votes cast against it. An ordinary resolution approving material related party transactions also passed with 64.21% valid non-promoter votes in favor, after 72.55 crore promoter votes were excluded as interested parties.
- AGM held on September 11, 2026 with 72 shareholders attending via video conferencing out of 204,408 total shareholders.
- Fundraise enabling resolution passed with 98.58% total votes in favor (74.89 crore votes), but 60.90% of institutional votes were against.
- Material Related Party Transactions approved with 64.21% valid votes (2.20 crore in favor vs 1.23 crore against) after excluding 72.55 crore interested promoter votes.
- Payment of interim dividend and declaration of final dividend for FY26 confirmed with 99.99% votes in favor.
Fineotex Chemical Limited (FCL) concluded its 23rd Annual General Meeting on September 11, 2026, with 72 members attending virtually. Key tabled agenda items included the adoption of FY26 financial statements, declaration of a final dividend, approval for raising funds via equity or eligible securities, and material related-party transactions. Official voting results will be declared within two working days of the meeting's conclusion.
- 23rd Annual General Meeting held on September 11, 2026, with 72 members in attendance via VC/OAVM.
- Remote e-voting was active from September 08, 2026, to September 10, 2026, with a cut-off date of September 04, 2026.
- Special resolution tabled to approve raising of funds by way of equity shares or other eligible securities.
- Ordinary resolution tabled to approve declaration of a final dividend for FY 2025-26.
- Voting results along with scrutinizer report to be declared within 2 working days.
Fineotex Chemical Limited (market cap ₹2,596 Cr) has announced an in-person plant visit for 14 institutional investors and analysts at its Ambernath manufacturing facility in Maharashtra on Friday, September 11, 2026. Participating institutions include Quantum AMC, JM Financial, Alchemy Capital, and Burman Capital, among others. The company stated that no unpublished price sensitive information (UPSI) will be discussed during the visit. This is a routine institutional interaction to showcase facility operations without any direct operational or financial changes.
- Plant visit scheduled for Friday, September 11, 2026, starting at 08:00 AM IST
- Participation confirmed from 14 institutional investors and analyst firms
- Location is the company's manufacturing facility at Anand Nagar, Additional M.I.D.C., Ambernath, Maharashtra
- No price sensitive information will be disclosed or discussed as per SEBI regulations
Fineotex Chemical Limited has notified exchanges regarding an in-person plant visit for 14 institutional investors and analyst firms scheduled for Friday, September 11, 2026, at 08:00 AM IST. The visit will take place at the company's facility located in Anand Nagar, Additional M.I.D.C., Ambernath, Maharashtra. Participating institutions include Electrum Capital, Burman Capital, Quantum AMC, JM Financial, and Alchemy Capital, among others. The company stated that no Unpublished Price Sensitive Information (UPSI) will be disclosed during the event.
- Plant visit scheduled for Friday, September 11, 2026 at 08:00 AM IST
- A total of 14 institutional investor and analyst firms participating
- Venue is the Ambernath Plant located at B-24, Anand Nagar, Additional M.I.D.C., Maharashtra
- Key participating entities include JM Financial, Burman Capital, and Quantum AMC
- Company confirmed no unpublished price sensitive information will be shared
Fineotex Chemical Limited's wholly owned subsidiary, Fineotex Biotex HealthGuard FZE, has incorporated a new 100% step-down subsidiary named Fineotex Holdings Inc. in Delaware, USA. The Certificate of Incorporation was received on September 1, 2026. The new entity has a current turnover of Nil and is established to undertake specialty chemical activities (manufacturing, trading, and development) as well as strategic investments and growth opportunities in the US. No upfront acquisition cost was involved.
- Incorporated Fineotex Holdings Inc. in the State of Delaware, USA as a 100% step-down subsidiary.
- Formed under wholly owned subsidiary Fineotex Biotex HealthGuard FZE.
- Current turnover is Nil as it is a newly incorporated entity.
- Objective includes manufacturing, trading, R&D in specialty chemicals, and pursuing strategic M&A in allied businesses.
ICRA has upgraded Fineotex Chemical Limited's long-term credit rating to [ICRA]AA- (Stable) from [ICRA]A+ (Positive) and reaffirmed its short-term rating at [ICRA]A1+ across Rs 100.00 crore of bank facilities. The rating action reflects significant improvements in operating scale and geographical diversification following the FY2026 acquisition of a 53.33% stake in the US-based CrudeChem Technologies (CCT) Group (~USD 65 million FY2025 revenue). ICRA highlighted the company's strong financial profile, supported by negligible debt, strong liquidity, and healthy demand across North American oilfield chemicals and domestic textile chemical segments.
- Long-term bank facilities rating upgraded to [ICRA]AA- (Stable) from [ICRA]A+ (Positive) effective August 24, 2026.
- Short-term bank facilities rating reaffirmed at the highest tier of [ICRA]A1+.
- Total bank facilities rated under the program stand at Rs 100.00 crore.
- Upgrade factors in the scale-up from the 53.33% acquisition of US-based CCT Group (reported FY2025 revenue of ~USD 65 million).
ICRA has upgraded the long-term credit rating of Fineotex Chemical Limited (FCL) on its Rs 100.00 crore bank facilities to [ICRA]AA- (Stable) from [ICRA]A+ (Positive), while reaffirming its short-term rating at [ICRA]A1+. The rating action reflects a significant expansion in operating scale and geographic diversification following FCL's FY2026 acquisition of a 53.33% controlling stake in US-based CrudeChem Technologies (CCT) Group, which clocked ~USD 65 million (~Rs 540+ Cr) in FY2025 revenue. ICRA highlighted that the group's financial risk profile remains strong, supported by negligible debt (D/E 0.00x), solid liquidity, and healthy demand across North American oilfield chemicals.
- Long-term bank facility rating upgraded to [ICRA]AA- (Stable) from [ICRA]A+ (Positive).
- Short-term credit rating reaffirmed at the highest tier of [ICRA]A1+.
- Total bank facilities rated by ICRA stand at Rs 100.00 crore (including Rs 57.00 crore unallocated limits).
- Acquired 53.33% controlling stake in US-based CCT Group, which reported ~USD 65 million revenue in FY2025.
Fineotex Chemical Limited has issued the notice for its 23rd Annual General Meeting scheduled for September 11, 2026. Among key agenda items, the company is seeking an enabling approval from shareholders to raise up to Rs 800 crore via equity or convertible securities, which represents ~42.2% of its current market capitalization of Rs 1,894 crore. Additionally, the AGM will vote on approving a final dividend of Rs 0.05 per share and ratifying related party transactions up to Rs 500 crore. The record/cut-off date for dividend eligibility and voting has been set for September 04, 2026.
- Enabling special resolution sought to raise funds up to Rs 800 crore through equity or convertible securities (~42.2% of market cap).
- Approval sought for material related party transactions aggregating up to Rs 500 crore on an arm's length basis.
- Proposed final dividend of Rs 0.05 per share (in addition to confirmed interim dividend of Rs 0.80 per share).
- Record date and cut-off date for AGM voting and dividend entitlement set as September 04, 2026.
- 23rd AGM to be held virtually on Friday, September 11, 2026, with remote e-voting from September 08 to September 10, 2026.
Fineotex Chemical has fixed September 04, 2026, as the record date for its 23rd Annual General Meeting (AGM) and the payment of final dividend. The AGM is scheduled for September 11, 2026, with dividend disbursement to eligible shareholders on or before September 30, 2026. In addition, the Board approved an enabling proposal to raise funds via equity or equity-linked securities through QIP, preferential issue, or private placement, subject to shareholder approval. Specific details regarding the fundraise quantum and pricing were not disclosed in the filing.
- Fixed Record Date as September 04, 2026, for final dividend eligibility and 23rd AGM attendance
- 23rd Annual General Meeting scheduled for September 11, 2026, via Video Conferencing
- Dividend payment timeline finalized for disbursement on or before September 30, 2026
- Approved enabling resolution for fundraising via equity or equity-linked instruments subject to shareholder approval
Fineotex Chemical Limited (FCL) announced that its Board of Directors has approved a proposal to raise funds through equity shares or equity-linked securities via QIP, preferential issue, or private placement, subject to shareholder approval. The company has scheduled its 23rd Annual General Meeting (AGM) for September 11, 2026. Additionally, the record date for the AGM and final dividend has been set as September 4, 2026, with payment slated on or before September 30, 2026. The specific quantum and pricing for the fundraise have not been disclosed at this stage.
- Board approved an enabling resolution to raise funds via equity or equity-linked securities through QIP/preferential issue.
- 23rd Annual General Meeting scheduled for September 11, 2026, via Video Conferencing.
- Record date for AGM and final dividend eligibility fixed as September 4, 2026.
- Final dividend, if approved by members, will be paid on or before September 30, 2026.
Fineotex Chemical Limited's board has approved an enabling resolution to raise capital via equity shares or equity-linked securities through private placement, QIP, preferential issue, or FPO, subject to shareholder and regulatory approvals. The company scheduled its 23rd Annual General Meeting (AGM) for September 11, 2026. The record date for the AGM and final dividend entitlement has been fixed as September 4, 2026, with dividend distribution to be completed on or before September 30, 2026. The quantum and pricing of the proposed fundraise were not disclosed in this filing.
- Board approved an enabling resolution to raise funds via equity or equity-linked instruments (QIP/Preferential/Private Placement).
- Record date for dividend entitlement and 23rd AGM fixed as September 4, 2026.
- 23rd Annual General Meeting to be held via Video Conferencing on September 11, 2026.
- Final dividend, if approved at AGM, will be disbursed on or before September 30, 2026.
Fineotex Chemical Limited (FCL) reported a massive 165% YoY jump in total income to ₹386.72 Cr for Q1 FY27, driven by the full integration of its U.S. subsidiary, CrudeChem. The company successfully expanded its Texas manufacturing capacity to 148,000 metric tons per year to service the North American oilfield chemicals market. Gross margins improved significantly to 35.42% from 31.35% in the previous year, reflecting a shift toward higher-margin specialty products. Management also highlighted new business wins in Saudi Arabia linked to a USD 8 billion Aramco project and expansion into Canada and South American markets.
- Total income for Q1 FY27 surged 165% YoY to ₹386.72 Cr from ₹146.62 Cr.
- Texas manufacturing capacity expanded to approximately 148,000 metric tons per year.
- Gross profit increased by 190% YoY to ₹133.4 Cr with margins at 35.42%.
- Secured a specialty chemical package for a customer's USD 8 billion Aramco order.
- Expanded international footprint into Canada, Suriname, and Guyana during the quarter.
Fineotex Chemical Limited (FCL) has published the audio recording of its investor and analyst conference call held on July 24, 2026. The call focused on the company's financial performance for Q1 FY 2026-2027. This follows a strong Mar 2026 quarter where revenue reached Rs 313.73 Cr, significantly higher than the Rs 119.78 Cr reported in Mar 2025. The recording provides management's perspective on their 20% YoY volume growth target and expansion into high-margin segments like Oil & Gas.
- Earnings call conducted on July 24, 2026, to discuss Q1 FY27 results
- Company maintains a TTM revenue of Rs 772 Cr with an OPM of 17.4%
- Mar 2026 quarterly revenue of Rs 313.73 Cr shows significant scaling compared to FY25 averages
- Promoter holding remains stable at 62.3% as of the latest reporting period
- Management continues to target 20% YoY volume growth through the Ambernath facility ramp-up
Financial Performance
Revenue Growth by Segment
Consolidated revenue reached INR 569 Cr in FY2024, up 10% from INR 517 Cr in FY2023. The Textile segment historically contributed 88% of revenue, but the company is diversifying into Home Care, Hygiene, and Oil & Gas. H1 FY2026 revenue stood at INR 274.78 Cr, a slight decrease of 4.5% compared to INR 287.63 Cr in H1 FY2025.
Geographic Revenue Split
Domestic sales accounted for 75% of revenue in Q2 FY2026, while exports contributed 25%. The company has a presence in approximately 70 countries, with exports forming 22% of total revenue in FY2024.
Profitability Margins
Gross margins expanded to 38.45% in Q2 FY2026 from 33.53% in Q1 FY2026. Net Profit Margin was 21.3% in FY2024 compared to 17.3% in FY2023. Operating margins have been maintained in a range of 18-22% over the last five years due to cost pass-through abilities.
EBITDA Margin
EBITDA margin stood at 22.53% in Q2 FY2026, a sequential improvement of 415 basis points from 18.38% in Q1 FY2026. FY2024 EBITDA margin was 26.1%, up from 21.8% in FY2023.
Capital Expenditure
The company raised funds through a preferential allotment of equity shares and warrants in FY2024 to support liquidity and potential expansion. Specific historical INR Cr values for capex are not disclosed, but the company recently ramped up newly added capacities at Ambernath.
Credit Rating & Borrowing
ICRA upgraded FCL's rating to [ICRA]A (Positive) from [ICRA]A- (Stable). CRISIL maintains a rating of CRISIL A/Stable. Interest coverage ratio was robust at 111.5x in FY2024 and 178.63x in FY2025, reflecting minimal borrowing costs.
Operational Drivers
Raw Materials
Crude oil derivatives and specialty chemical intermediates. Raw material costs accounted for INR 175.87 Cr in H1 FY2026, representing approximately 64% of total revenue.
Import Sources
Raw materials are sourced from both domestic suppliers and international markets. Specific countries are not disclosed, though the company has manufacturing facilities in India and Malaysia.
Capacity Expansion
Current production volume stood at 60,692.40 MT in FY2024. The company has fungible manufacturing facilities in Navi Mumbai, Ambernath, and Selangor (Malaysia). Expansion is focused on ramping up utilization of these recently commissioned capacities.
Raw Material Costs
Raw material costs were INR 84.76 Cr in Q2 FY2026. The company manages volatility through formula-based pricing and a cost pass-through mechanism, allowing it to maintain operating margins despite crude oil price fluctuations.
Manufacturing Efficiency
Capacity utilization is being ramped up to drive cash generation. The company uses in-house R&D to improve product mix and raw material efficiencies, contributing to a 500 bps QoQ gross margin expansion in Q2 FY2026.
Strategic Growth
Expected Growth Rate
20%
Growth Strategy
Growth will be achieved through a 20% YoY volume target, ramping up the Ambernath facility, and diversifying into high-margin segments like Oil & Gas and FMCG (detergents). The company is leveraging JVs with Euroye-CTC and HealthGuard to expand its product portfolio and international footprint.
Products & Services
Specialty chemicals for textile pre-treatment, dyeing, printing, and finishing; detergents and handwashes for the health and hygiene segment; and drilling chemicals for the Oil & Gas industry.
Brand Portfolio
Biotex (Malaysia-based subsidiary), HealthGuard (JV partner brand).
New Products/Services
Recent entries include performance boosters for FMCG detergent companies and specialized drilling chemicals for the Oil & Gas sector, which are expected to contribute to higher gross margins.
Market Expansion
Targeting deeper penetration in the ~70 countries where it currently operates, with a focus on expanding the non-textile segment to balance the revenue profile.
Market Share & Ranking
FCL is a leading manufacturer of specialty and performance chemicals for textiles in India.
Strategic Alliances
Joint Ventures with Euroye-CTC and HealthGuard (Australia) to acquire new customers and diversify geographic presence.
External Factors
Industry Trends
The specialty chemicals industry is shifting toward sustainable and certified products. FCL is positioned for this through ZDHC and Blue Design certifications. The industry is growing, and FCL is moving from a textile-heavy focus to a balanced multi-segment profile.
Competitive Landscape
Faces intense competition from large European multinational players with high capital bases and established market dominance.
Competitive Moat
Moat is built on 40+ years of promoter experience, customized product offerings, and prestigious certifications (ZDHC, USEPA) that act as entry barriers. These are sustainable due to long-standing client relationships and technical expertise.
Macro Economic Sensitivity
Sensitive to global textile demand and household consumption trends. Geopolitical tensions can cause order postponements.
Consumer Behavior
Rising household consumption in India is driving demand for the company's home care and hygiene products.
Geopolitical Risks
Exposure to evolving US tariff environments and geopolitical instability in export regions which can delay shipments.
Regulatory & Governance
Industry Regulations
Subject to tightening environmental and safety regulations in the chemical industry. Compliance is maintained through Blue Design and Star Export House certifications.
Environmental Compliance
FCL is ZDHC Gateway certified and compliant with USEPA standards. CSR obligation for the financial year was INR 148.66 Lakhs.
Taxation Policy Impact
The effective tax rate for H1 FY2026 was approximately 23.6% (INR 15.78 Cr tax on INR 66.89 Cr PBT).
Legal Contingencies
The Board states there are no risks threatening the existence of the company. Specific pending court case values are not disclosed.
Risk Analysis
Key Uncertainties
Volatility in crude oil prices (raw material) and intense competition from global players are the primary business risks.
Geographic Concentration Risk
75% of revenue is concentrated in the Indian domestic market as of Q2 FY2026.
Third Party Dependencies
Dependency on raw material suppliers for imported chemicals, though specific vendor names are not disclosed.
Technology Obsolescence Risk
Risk of competitors introducing new products with enhanced capabilities; mitigated by FCL's continuous R&D and product innovation.
Credit & Counterparty Risk
Low risk due to established relationships with reputed, large-scale domestic and international clients.